Viewing StudyNCT00090207

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00090207
Status: COMPLETED
Last Update Posted: 2017-04-24
First Post: 2004-08-25
Brief Title: Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting CINV Associated With Highly Emetogenic Chemotherapy 0869-801COMPLETED
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Vomiting
Nausea
Keywords: